Results 171 to 180 of about 59,572 (271)

A Case of Clozapine Toxicity Caused by Infection in a Patient with Treatment-Resistant Schizophrenia. [PDF]

Int Med Case Rep J
Tomita T, Ozawa S, Akasaka K, Nakamura K.   +3 more
europepmc   +1 more source

Clinical Characteristics Associated With Response and Remission From Depression Using Measurement‐Based Care

Psychiatric Research and Clinical Practice, EarlyView.
Objective Measurement‐based care (MBC) is a vital tool in outpatient psychiatric care, enhancing treatment outcomes through systematic symptom monitoring. This study aimed to identify factors associated with remission and response in depression treatment using MBC, focusing on longitudinal changes in Patient Health Questionnaire‐9 (PHQ‐9) scores ...
Andres R. Schneeberger, Joelle Robinett, Katia M. Harlé, Eve Lasswell, Kristen L. Duarte, Ashley Clark, Savita G. Bhakta, Jessica Thackaberry, Kelly C. Lee   +8 more
wiley   +1 more source

Perspectives and Experiences of People Receiving Care on a De‐escalation Intervention to Reduce Restrictive Practices in Acute Mental Health Units

International Journal of Mental Health Nursing, Volume 35, Issue 4, August 2026.
ABSTRACT Interventions aimed at reducing restrictive practices are also designed to enhance the service experience in acute mental health units. However, people with experience of coercive engagement with these services are seldom involved as active contributors in evaluative research on interventions to reduce restrictive practices.
Esario IV Daguman, Dane Owen, Jacqui Yoxall, Richard Lakeman, Marie Hutchinson   +4 more
wiley   +1 more source

ACKR1/Duffy‐null genotype testing for clozapine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, Volume 92, Issue 7, Page 1977-1990, July 2026.
Abstract Clozapine is licenced for treatment‐resistant schizophrenia and psychosis in Parkinson's disease. In the United Kingdom, there is a mandatory requirement for absolute neutrophil count (ANC) and white blood cell count (WBC) monitoring to safeguard against agranulocytosis.
Stephen Murtough, Oriella Stellakis, Daisy Mills, Blanca Bjourson, Vicky Chaplin, Dharmisha Chauhan, Bev Chipp, Marius Cotic, Jana de Villiers, Olubanké Dzahini, Frances Elmslie, Katie Evans, Shreyans Gandhi, Dyfrig A. Hughes, Huajie Jin, Daniele Panconesi, Anna Skowronska, Sanjay M. Sisodiya, Ed Silva, Vicky Stinton, Sara Stuart‐Smith, Sarah Tarrant, David Taylor, Lauren Varney, James T. R. Walters, Michelle Wood, Jessica Woodley, Cinzia Dello Russo, Munir Pirmohamed, Elvira Bramon   +29 more
wiley   +1 more source

Immune System Alterations in Treatment-Resistant Schizophrenia: A Systematic Review of the Current Evidence and Future Directions. [PDF]

Int J Mol Sci
Krzystanek M, Bieś R, Bąk-Sosnowska M.
europepmc   +1 more source

Hoping Against Hope: Gurkha Veterans' Narratives of Mental Health, Activism, and Justice

Journal of Community &Applied Social Psychology, Volume 36, Issue 4, July/August 2026.
ABSTRACT Gurkha veterans hold a celebrated yet marginalised position within the British military system, where longstanding inequalities continue to shape their post‐service lives. Although Gurkha activism has become increasingly visible, little is known about how veterans themselves understand mental health within a prolonged struggle for justice ...
Krishtina Gurung, Maja Jankowska, Krishna Adhikari   +2 more
wiley   +1 more source

Clozapine prescribing in treatment-resistant schizophrenia - an updated systematic literature review of barriers and facilitators among clinicians. [PDF]

Eur J Clin Pharmacol
Nolan S, Sahm LJ, Fitzgerald I.
europepmc   +1 more source

Patient‐ and Clinician‐Related Factors Associated With the Reduction in Opioid Use Among Adults With Chronic Non‐Cancer Pain: A Systematic Review

Clinical Pharmacology &Therapeutics, Volume 120, Issue 1, Page 66-80, July 2026.
Despite known risks, opioids are widely used for chronic non‐cancer pain (CNCP). Clinical guidelines now recommend deprescribing, but factors predicting success are poorly understood. This systematic review aimed to identify clinician and patient factors associated with attaining successful opioid dose reduction or discontinuation in adults with CNCP ...
Alessandra C. Marcelo, Sarah N. Hilmer, David J. Hunter, Stephanie Mathieson, Riyaas Mohamed, Leo Li, Natalie Fung, Anthony Yue, Manuela L. Ferreira   +8 more
wiley   +1 more source

Effectiveness of a Psychiatrist‐Led Clinic for Metabolic Health in Severe Mental Illness: A Retrospective Chart Review Study

Acta Psychiatrica Scandinavica, Volume 154, Issue 1, Page 74-88, July 2026.
ABSTRACT Background Psychotropic medications are associated with serious metabolic adverse effects, which contribute to an increased risk of cardiometabolic comorbidities in patients with severe mental illness (SMI). Several intervention strategies are available to mitigate these metabolic adverse effects; however, data on their utility in real‐world ...
Nicolette Stogios, Femin Prasad, Riddhita De, Kateryna Maksyutynska, Akash PrasannaKumar, Vittal Korann, Tariq Ahmed, Marcos Sanches, Leah Burton, Mohammed A. Alarabi, Tanner Isinger, Michelle Desanti, Rebecca Oliveira, Daphne J. Korczak, Ariel Graff‐Guerrero, Gary Remington, Margaret K. Hahn, Sri Mahavir Agarwal   +17 more
wiley   +1 more source

In rats, neurodevelopmental disorders induced by maternal hypoxia are associated with attenuated excitatory neurotransmission in the cingulate cortex

British Journal of Pharmacology, Volume 183, Issue 13, Page 3723-3742, July 2026.
Background and Purpose Maternal hypoxia is a recognised risk factor for neurodevelopmental disorders in offspring. Although rodent models of hypoxia have been reported, the detailed pathogenesis of maternal hypoxia‐induced neurodevelopmental disorders remains unclear.
Kentaro Tokudome, Masaaki Ueki, Takujiro Homma, Shinji Matsunaga, Saki Shimizu, Yukihiro Ohno, Shuhei Tomita   +6 more
wiley   +1 more source